Prime Capital Investment Advisors, LLC Amgen Inc Transaction History

Prime Capital Investment Advisors, LLC

$6.88 Billion
Q3 2024

A detailed history of Prime Capital Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 48,421 shares of AMGN stock, worth $13.7 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

48,421

Previous 46,954 3.12%

Holding current value

$13.7 Million

Previous $14.7 Million 6.35%

% of portfolio

0.23%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $453,860 - $494,936	1,467 Added 3.12%	48,421 $15.6 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $1.86 Million - $2.26 Million	-7,084 Reduced 13.11%	46,954 $14.7 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $2.23 Million - $2.7 Million	8,311 Added 18.18%	54,038 $15.4 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $1.76 Million - $1.99 Million	6,885 Added 17.73%	45,727 $13.2 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $302,174 - $375,157	1,382 Added 3.69%	38,842 $10.4 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $670,236 - $792,541	-3,128 Reduced 7.71%	37,460 $8.32 Million
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $3.28 Million - $4 Million	14,543 Added 55.84%	40,588 $9.81 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $5.52 Million - $7.01 Million	24,083 Added 1227.47%	26,045 $6.84 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $120,535 - $135,941	537 Added 37.68%	1,962 $442,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $53,063 - $59,050	230 Added 19.25%	1,425 $347,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $29,434 - $33,684	148 Added 14.14%	1,195 $269,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $127,786 - $149,717	-602 Reduced 36.51%	1,047 $223,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $192,236 - $213,272	823 Added 99.64%	1,649 $402,000
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $69,457 - $80,941	-313 Reduced 27.48%	826 $206,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $74,218 - $88,380	343 Added 43.09%	1,139 $262,000
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $6,570 - $7,306	-28 Reduced 3.4%	796 $202,000
Q2 2020 Jul 17, 2020	SELL	$197.81 - $242.74 $76,948 - $94,425	-389 Reduced 32.07%	824 $194,000
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $111,166 - $147,437	610 Added 101.16%	1,213 $246,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $567 - $729	3 Added 0.5%	603 $145,000
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $82,528 - $98,885	474 Added 376.19%	600 $116,000
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $500 - $586	-3 Reduced 2.33%	126 $23,000
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $15,373 - $17,329	-85 Reduced 39.72%	129 $25,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $38,177 - $44,565	214 New	214 $42,000

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.

Account

Prime Capital Investment Advisors, LLC Amgen Inc Transaction History